Lynderm Research

Markham, Ontario L3P1X2

0 studies enrolling now · 8 studies all time

What they study most

Acne Vulgaris, Allergic Rhinitis, Asthma, Atopic Dermatitis, Eczema, Food Allergies, Moderate Psoriasis, Plaque Psoriasis, Psoriasis, Psoriasis (PsO), Psoriasis Vulgaris, Severe Psoriasis

Studies at this site

• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis — Running, not enrolling
• Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis — Running, not enrolling
• Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy — Completed
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris — Completed
• LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris — Completed
• A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp — Completed
• Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis — Stopped early